Adrian Rawcliffe Email & Phone

Chief Executive Officer @ Adaptimmune

Member Board Of Directors @ WAVE Life Sciences Ltd.

Chief Financial Officer @ Adaptimmune

SVP Finance North American Pharmaceuticals @ GlaxoSmithKline

SVP Finance North American Pharmaceuticals @ GSK

SVP WWBD and R and D Finance @ GlaxoSmithKline

SVP WWBD and R and D Finance @ GSK

SVP Worldwide Business Development @ GlaxoSmithKline

SVP Worldwide Business Development @ GSK

President and Managing Partner; SR one @ S.R. One Ltd

VP Transaction and Ventures, WWBD @ GlaxoSmithKline

VP Transaction and Ventures, WWBD @ GSK

VP Deal Structuring @ GlaxoSmithKline

VP Deal Structuring @ GSK

Associate Director, Group Financial Investigations and Planning @ GlaxoSmithKline

Associate Director, Group Financial Investigations and Planning @ GSK

1990 - 1993 Bachelor of Science @ Durham University

- @ Felsted School

Leadership, Accounting, CRO, Mergers, Biotechnology, Business Development, Negotiation, Life Sciences, Finance, Strategic Planning, Strategy, Drug Discovery, Lifesciences, Microsoft Excel, Drug Development, Cross Functional Team Leadership, Customer Service, Project Planning, Vaccines, Budgets, Business Strategy, Management, Due Diligence, Pharmaceutical Industry, Technology Transfer, Venture Capital, Mergers and Acquisitions, Commercialization, Biopharmaceuticals

Adrian Rawcliffe, based in Philadelphia, PA, US, is currently a Chief Executive Officer at Adaptimmune. Adrian Rawcliffe brings experience from previous roles at WAVE Life Sciences Ltd., Adaptimmune, GlaxoSmithKline, GSK, GlaxoSmithKline, GSK, GlaxoSmithKline, GSK, S.R. One Ltd, GlaxoSmithKline, GSK, GlaxoSmithKline, GSK, GlaxoSmithKline, GSK. Adrian Rawcliffe holds various educational qualifications including Bachelor of Science (1990 - 1993) from Durham University. With a robust skill set that includes Leadership, Accounting, CRO, Mergers, Biotechnology, Adrian Rawcliffe demonstrates proficiency in a wide range of areas.